CN Patent
CN1571659A — 含大量酸不稳定药物的颗粒
Assigned to Takeda Pharmaceutical Co Ltd · Expires 2005-01-26 · 21y expired
What this patent protects
本发明旨在提供含有高浓度酸不稳定化学药物(尤其是具有抗溃疡作用的苯并咪唑化合物等)的制剂如胶囊,其通过使用约12wt%或更多(基于全部颗粒剂)的酸不稳定化学药物并在其中混合碱式无机盐制备,以提供平均粒度为约600μm或更大的颗粒剂。
USPTO Abstract
本发明旨在提供含有高浓度酸不稳定化学药物(尤其是具有抗溃疡作用的苯并咪唑化合物等)的制剂如胶囊,其通过使用约12wt%或更多(基于全部颗粒剂)的酸不稳定化学药物并在其中混合碱式无机盐制备,以提供平均粒度为约600μm或更大的颗粒剂。
Drugs covered by this patent
- Dexilant (DEXLANSOPRAZOLE) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.